nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—Dactinomycin—sarcoma	0.0943	0.289	CbGbCtD
Lisinopril—ABCB1—Mitoxantrone—sarcoma	0.0844	0.259	CbGbCtD
Lisinopril—ABCB1—Vincristine—sarcoma	0.0581	0.178	CbGbCtD
Lisinopril—ABCB1—Etoposide—sarcoma	0.0532	0.163	CbGbCtD
Lisinopril—ABCB1—Doxorubicin—sarcoma	0.0363	0.111	CbGbCtD
Lisinopril—ACE—forelimb zeugopod—sarcoma	0.0304	0.148	CbGeAlD
Lisinopril—ACE—pulmonary artery—sarcoma	0.0227	0.11	CbGeAlD
Lisinopril—ACE—forelimb—sarcoma	0.0153	0.0742	CbGeAlD
Lisinopril—ACE—umbilical vein—sarcoma	0.015	0.0729	CbGeAlD
Lisinopril—ACE—hindlimb—sarcoma	0.0137	0.0668	CbGeAlD
Lisinopril—ACE—arm—sarcoma	0.0131	0.0638	CbGeAlD
Lisinopril—ACE—appendage—sarcoma	0.0118	0.0573	CbGeAlD
Lisinopril—ACE2—hematopoietic system—sarcoma	0.0107	0.0519	CbGeAlD
Lisinopril—ACE2—cardiac atrium—sarcoma	0.00811	0.0394	CbGeAlD
Lisinopril—ACE—endothelium—sarcoma	0.00711	0.0346	CbGeAlD
Lisinopril—ACE2—testis—sarcoma	0.00586	0.0285	CbGeAlD
Lisinopril—ACE2—liver—sarcoma	0.00554	0.0269	CbGeAlD
Lisinopril—ACE2—lymph node—sarcoma	0.00424	0.0206	CbGeAlD
Lisinopril—ACE—embryo—sarcoma	0.00391	0.019	CbGeAlD
Lisinopril—ACE—seminal vesicle—sarcoma	0.00368	0.0179	CbGeAlD
Lisinopril—ACE—hematopoietic system—sarcoma	0.00349	0.017	CbGeAlD
Lisinopril—ACE—connective tissue—sarcoma	0.00336	0.0163	CbGeAlD
Lisinopril—ACE—smooth muscle tissue—sarcoma	0.00308	0.015	CbGeAlD
Lisinopril—ACE—cardiac atrium—sarcoma	0.00265	0.0129	CbGeAlD
Lisinopril—SLC15A1—liver—sarcoma	0.00252	0.0123	CbGeAlD
Lisinopril—ACE—lymphoid tissue—sarcoma	0.00246	0.012	CbGeAlD
Lisinopril—ACE—bone marrow—sarcoma	0.00224	0.0109	CbGeAlD
Lisinopril—ACE—testis—sarcoma	0.00191	0.0093	CbGeAlD
Lisinopril—ACE—liver—sarcoma	0.00181	0.0088	CbGeAlD
Lisinopril—ABCB1—myometrium—sarcoma	0.00143	0.00696	CbGeAlD
Lisinopril—ACE—lymph node—sarcoma	0.00139	0.00674	CbGeAlD
Lisinopril—ABCB1—embryo—sarcoma	0.00138	0.00669	CbGeAlD
Lisinopril—ABCB1—seminal vesicle—sarcoma	0.00129	0.00629	CbGeAlD
Lisinopril—ABCB1—hematopoietic system—sarcoma	0.00123	0.00598	CbGeAlD
Lisinopril—ABCB1—uterus—sarcoma	0.000929	0.00451	CbGeAlD
Lisinopril—ABCB1—lymphoid tissue—sarcoma	0.000866	0.00421	CbGeAlD
Lisinopril—ABCB1—bone marrow—sarcoma	0.000788	0.00383	CbGeAlD
Lisinopril—ABCB1—testis—sarcoma	0.000674	0.00328	CbGeAlD
Lisinopril—ABCB1—liver—sarcoma	0.000637	0.0031	CbGeAlD
Lisinopril—ABCB1—lymph node—sarcoma	0.000489	0.00237	CbGeAlD
Lisinopril—Dysuria—Epirubicin—sarcoma	0.000459	0.000981	CcSEcCtD
Lisinopril—Neutropenia—Epirubicin—sarcoma	0.000459	0.000981	CcSEcCtD
Lisinopril—Dizziness—Thiotepa—sarcoma	0.000458	0.00098	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Epirubicin—sarcoma	0.000456	0.000975	CcSEcCtD
Lisinopril—Asthma—Doxorubicin—sarcoma	0.000454	0.000971	CcSEcCtD
Lisinopril—Influenza—Doxorubicin—sarcoma	0.000454	0.000971	CcSEcCtD
Lisinopril—Hypersensitivity—Vincristine—sarcoma	0.000453	0.000968	CcSEcCtD
Lisinopril—Eosinophilia—Doxorubicin—sarcoma	0.00045	0.000961	CcSEcCtD
Lisinopril—Photosensitivity reaction—Epirubicin—sarcoma	0.000448	0.000958	CcSEcCtD
Lisinopril—Paraesthesia—Etoposide—sarcoma	0.000447	0.000956	CcSEcCtD
Lisinopril—Weight increased—Epirubicin—sarcoma	0.000447	0.000955	CcSEcCtD
Lisinopril—Pancreatitis—Doxorubicin—sarcoma	0.000445	0.000952	CcSEcCtD
Lisinopril—Weight decreased—Epirubicin—sarcoma	0.000444	0.000949	CcSEcCtD
Lisinopril—Dyspnoea—Etoposide—sarcoma	0.000444	0.000949	CcSEcCtD
Lisinopril—Hyperglycaemia—Epirubicin—sarcoma	0.000443	0.000947	CcSEcCtD
Lisinopril—Somnolence—Etoposide—sarcoma	0.000443	0.000946	CcSEcCtD
Lisinopril—Angina pectoris—Doxorubicin—sarcoma	0.000442	0.000946	CcSEcCtD
Lisinopril—Hypersensitivity—Mitoxantrone—sarcoma	0.000441	0.000943	CcSEcCtD
Lisinopril—Asthenia—Vincristine—sarcoma	0.000441	0.000943	CcSEcCtD
Lisinopril—Vomiting—Thiotepa—sarcoma	0.000441	0.000942	CcSEcCtD
Lisinopril—Pneumonia—Epirubicin—sarcoma	0.00044	0.000941	CcSEcCtD
Lisinopril—Vomiting—Dactinomycin—sarcoma	0.000437	0.000935	CcSEcCtD
Lisinopril—Rash—Thiotepa—sarcoma	0.000437	0.000934	CcSEcCtD
Lisinopril—Bronchitis—Doxorubicin—sarcoma	0.000437	0.000934	CcSEcCtD
Lisinopril—Dermatitis—Thiotepa—sarcoma	0.000437	0.000934	CcSEcCtD
Lisinopril—Headache—Thiotepa—sarcoma	0.000434	0.000928	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000434	0.000928	CcSEcCtD
Lisinopril—Rash—Dactinomycin—sarcoma	0.000434	0.000927	CcSEcCtD
Lisinopril—Decreased appetite—Etoposide—sarcoma	0.000433	0.000925	CcSEcCtD
Lisinopril—Pancytopenia—Doxorubicin—sarcoma	0.000431	0.000922	CcSEcCtD
Lisinopril—Renal failure—Epirubicin—sarcoma	0.00043	0.00092	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Etoposide—sarcoma	0.00043	0.000919	CcSEcCtD
Lisinopril—Asthenia—Mitoxantrone—sarcoma	0.00043	0.000918	CcSEcCtD
Lisinopril—Fatigue—Etoposide—sarcoma	0.000429	0.000918	CcSEcCtD
Lisinopril—Neuropathy peripheral—Epirubicin—sarcoma	0.000429	0.000917	CcSEcCtD
Lisinopril—Jaundice—Epirubicin—sarcoma	0.000427	0.000912	CcSEcCtD
Lisinopril—Pain—Etoposide—sarcoma	0.000426	0.00091	CcSEcCtD
Lisinopril—Constipation—Etoposide—sarcoma	0.000426	0.00091	CcSEcCtD
Lisinopril—Urinary tract infection—Epirubicin—sarcoma	0.000425	0.00091	CcSEcCtD
Lisinopril—Neutropenia—Doxorubicin—sarcoma	0.000425	0.000908	CcSEcCtD
Lisinopril—Dysuria—Doxorubicin—sarcoma	0.000425	0.000908	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000422	0.000902	CcSEcCtD
Lisinopril—Diarrhoea—Vincristine—sarcoma	0.000421	0.000899	CcSEcCtD
Lisinopril—Sweating—Epirubicin—sarcoma	0.00042	0.000897	CcSEcCtD
Lisinopril—Haematuria—Epirubicin—sarcoma	0.000417	0.000892	CcSEcCtD
Lisinopril—Photosensitivity reaction—Doxorubicin—sarcoma	0.000415	0.000886	CcSEcCtD
Lisinopril—Hepatobiliary disease—Epirubicin—sarcoma	0.000414	0.000885	CcSEcCtD
Lisinopril—Weight increased—Doxorubicin—sarcoma	0.000413	0.000884	CcSEcCtD
Lisinopril—Epistaxis—Epirubicin—sarcoma	0.000413	0.000883	CcSEcCtD
Lisinopril—Nausea—Thiotepa—sarcoma	0.000412	0.00088	CcSEcCtD
Lisinopril—Weight decreased—Doxorubicin—sarcoma	0.000411	0.000878	CcSEcCtD
Lisinopril—Sinusitis—Epirubicin—sarcoma	0.000411	0.000878	CcSEcCtD
Lisinopril—Feeling abnormal—Etoposide—sarcoma	0.00041	0.000877	CcSEcCtD
Lisinopril—Hyperglycaemia—Doxorubicin—sarcoma	0.00041	0.000876	CcSEcCtD
Lisinopril—Diarrhoea—Mitoxantrone—sarcoma	0.00041	0.000876	CcSEcCtD
Lisinopril—Nausea—Dactinomycin—sarcoma	0.000409	0.000874	CcSEcCtD
Lisinopril—Agranulocytosis—Epirubicin—sarcoma	0.000408	0.000873	CcSEcCtD
Lisinopril—Pneumonia—Doxorubicin—sarcoma	0.000407	0.000871	CcSEcCtD
Lisinopril—Gastrointestinal pain—Etoposide—sarcoma	0.000407	0.000871	CcSEcCtD
Lisinopril—Dizziness—Vincristine—sarcoma	0.000406	0.000869	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000401	0.000858	CcSEcCtD
Lisinopril—Bradycardia—Epirubicin—sarcoma	0.0004	0.000855	CcSEcCtD
Lisinopril—Renal failure—Doxorubicin—sarcoma	0.000398	0.000851	CcSEcCtD
Lisinopril—Neuropathy peripheral—Doxorubicin—sarcoma	0.000397	0.000849	CcSEcCtD
Lisinopril—Urticaria—Etoposide—sarcoma	0.000396	0.000846	CcSEcCtD
Lisinopril—Jaundice—Doxorubicin—sarcoma	0.000395	0.000844	CcSEcCtD
Lisinopril—Rhinitis—Epirubicin—sarcoma	0.000394	0.000842	CcSEcCtD
Lisinopril—Body temperature increased—Etoposide—sarcoma	0.000394	0.000842	CcSEcCtD
Lisinopril—Abdominal pain—Etoposide—sarcoma	0.000394	0.000842	CcSEcCtD
Lisinopril—Urinary tract infection—Doxorubicin—sarcoma	0.000394	0.000842	CcSEcCtD
Lisinopril—Hepatitis—Epirubicin—sarcoma	0.000393	0.00084	CcSEcCtD
Lisinopril—Vomiting—Vincristine—sarcoma	0.000391	0.000836	CcSEcCtD
Lisinopril—Pharyngitis—Epirubicin—sarcoma	0.00039	0.000834	CcSEcCtD
Lisinopril—Sweating—Doxorubicin—sarcoma	0.000388	0.00083	CcSEcCtD
Lisinopril—Urinary tract disorder—Epirubicin—sarcoma	0.000388	0.00083	CcSEcCtD
Lisinopril—Rash—Vincristine—sarcoma	0.000388	0.000829	CcSEcCtD
Lisinopril—Dermatitis—Vincristine—sarcoma	0.000387	0.000828	CcSEcCtD
Lisinopril—Oedema peripheral—Epirubicin—sarcoma	0.000387	0.000827	CcSEcCtD
Lisinopril—Haematuria—Doxorubicin—sarcoma	0.000386	0.000825	CcSEcCtD
Lisinopril—Urethral disorder—Epirubicin—sarcoma	0.000385	0.000823	CcSEcCtD
Lisinopril—Headache—Vincristine—sarcoma	0.000385	0.000823	CcSEcCtD
Lisinopril—Hepatobiliary disease—Doxorubicin—sarcoma	0.000383	0.000819	CcSEcCtD
Lisinopril—Epistaxis—Doxorubicin—sarcoma	0.000382	0.000817	CcSEcCtD
Lisinopril—Vomiting—Mitoxantrone—sarcoma	0.000381	0.000814	CcSEcCtD
Lisinopril—Sinusitis—Doxorubicin—sarcoma	0.00038	0.000812	CcSEcCtD
Lisinopril—Agranulocytosis—Doxorubicin—sarcoma	0.000378	0.000808	CcSEcCtD
Lisinopril—Rash—Mitoxantrone—sarcoma	0.000377	0.000807	CcSEcCtD
Lisinopril—Dermatitis—Mitoxantrone—sarcoma	0.000377	0.000806	CcSEcCtD
Lisinopril—Headache—Mitoxantrone—sarcoma	0.000375	0.000802	CcSEcCtD
Lisinopril—Erythema multiforme—Epirubicin—sarcoma	0.000371	0.000794	CcSEcCtD
Lisinopril—Bradycardia—Doxorubicin—sarcoma	0.00037	0.000791	CcSEcCtD
Lisinopril—Hypersensitivity—Etoposide—sarcoma	0.000367	0.000784	CcSEcCtD
Lisinopril—Tinnitus—Epirubicin—sarcoma	0.000366	0.000783	CcSEcCtD
Lisinopril—Nausea—Vincristine—sarcoma	0.000365	0.000781	CcSEcCtD
Lisinopril—Flushing—Epirubicin—sarcoma	0.000365	0.00078	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—sarcoma	0.000364	0.000779	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—sarcoma	0.000364	0.000777	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—sarcoma	0.000361	0.000771	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—sarcoma	0.000359	0.000768	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—sarcoma	0.000358	0.000766	CcSEcCtD
Lisinopril—Asthenia—Etoposide—sarcoma	0.000357	0.000764	CcSEcCtD
Lisinopril—Angiopathy—Epirubicin—sarcoma	0.000356	0.000762	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—sarcoma	0.000356	0.000762	CcSEcCtD
Lisinopril—Nausea—Mitoxantrone—sarcoma	0.000356	0.00076	CcSEcCtD
Lisinopril—Mediastinal disorder—Epirubicin—sarcoma	0.000354	0.000757	CcSEcCtD
Lisinopril—Chills—Epirubicin—sarcoma	0.000353	0.000754	CcSEcCtD
Lisinopril—Pruritus—Etoposide—sarcoma	0.000352	0.000753	CcSEcCtD
Lisinopril—Arrhythmia—Epirubicin—sarcoma	0.000351	0.00075	CcSEcCtD
Lisinopril—Alopecia—Epirubicin—sarcoma	0.000347	0.000742	CcSEcCtD
Lisinopril—Mental disorder—Epirubicin—sarcoma	0.000344	0.000736	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—sarcoma	0.000344	0.000735	CcSEcCtD
Lisinopril—Erythema—Epirubicin—sarcoma	0.000342	0.000731	CcSEcCtD
Lisinopril—Malnutrition—Epirubicin—sarcoma	0.000342	0.000731	CcSEcCtD
Lisinopril—Diarrhoea—Etoposide—sarcoma	0.000341	0.000728	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—sarcoma	0.000339	0.000725	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—sarcoma	0.000337	0.000721	CcSEcCtD
Lisinopril—Flatulence—Epirubicin—sarcoma	0.000337	0.000721	CcSEcCtD
Lisinopril—Tension—Epirubicin—sarcoma	0.000336	0.000718	CcSEcCtD
Lisinopril—Dysgeusia—Epirubicin—sarcoma	0.000335	0.000716	CcSEcCtD
Lisinopril—Nervousness—Epirubicin—sarcoma	0.000332	0.00071	CcSEcCtD
Lisinopril—Back pain—Epirubicin—sarcoma	0.000331	0.000707	CcSEcCtD
Lisinopril—Angiopathy—Doxorubicin—sarcoma	0.00033	0.000705	CcSEcCtD
Lisinopril—Dizziness—Etoposide—sarcoma	0.000329	0.000704	CcSEcCtD
Lisinopril—Muscle spasms—Epirubicin—sarcoma	0.000329	0.000703	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—sarcoma	0.000328	0.0007	CcSEcCtD
Lisinopril—Chills—Doxorubicin—sarcoma	0.000326	0.000697	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—sarcoma	0.000325	0.000694	CcSEcCtD
Lisinopril—Vision blurred—Epirubicin—sarcoma	0.000322	0.000689	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—sarcoma	0.000321	0.000687	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—sarcoma	0.000318	0.000681	CcSEcCtD
Lisinopril—Ill-defined disorder—Epirubicin—sarcoma	0.000317	0.000678	CcSEcCtD
Lisinopril—Vomiting—Etoposide—sarcoma	0.000317	0.000677	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—sarcoma	0.000316	0.000677	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—sarcoma	0.000316	0.000677	CcSEcCtD
Lisinopril—Anaemia—Epirubicin—sarcoma	0.000316	0.000676	CcSEcCtD
Lisinopril—Rash—Etoposide—sarcoma	0.000314	0.000671	CcSEcCtD
Lisinopril—Dermatitis—Etoposide—sarcoma	0.000314	0.000671	CcSEcCtD
Lisinopril—Headache—Etoposide—sarcoma	0.000312	0.000667	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—sarcoma	0.000312	0.000667	CcSEcCtD
Lisinopril—Tension—Doxorubicin—sarcoma	0.000311	0.000664	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—sarcoma	0.00031	0.000663	CcSEcCtD
Lisinopril—Malaise—Epirubicin—sarcoma	0.000308	0.000659	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—sarcoma	0.000307	0.000657	CcSEcCtD
Lisinopril—Vertigo—Epirubicin—sarcoma	0.000307	0.000657	CcSEcCtD
Lisinopril—Syncope—Epirubicin—sarcoma	0.000307	0.000656	CcSEcCtD
Lisinopril—Leukopenia—Epirubicin—sarcoma	0.000306	0.000655	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—sarcoma	0.000306	0.000654	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—sarcoma	0.000304	0.00065	CcSEcCtD
Lisinopril—Palpitations—Epirubicin—sarcoma	0.000302	0.000646	CcSEcCtD
Lisinopril—Loss of consciousness—Epirubicin—sarcoma	0.000301	0.000643	CcSEcCtD
Lisinopril—Cough—Epirubicin—sarcoma	0.000298	0.000638	CcSEcCtD
Lisinopril—Vision blurred—Doxorubicin—sarcoma	0.000298	0.000638	CcSEcCtD
Lisinopril—Nausea—Etoposide—sarcoma	0.000296	0.000632	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—sarcoma	0.000294	0.000628	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—sarcoma	0.000292	0.000625	CcSEcCtD
Lisinopril—Myalgia—Epirubicin—sarcoma	0.000291	0.000623	CcSEcCtD
Lisinopril—Chest pain—Epirubicin—sarcoma	0.000291	0.000623	CcSEcCtD
Lisinopril—Arthralgia—Epirubicin—sarcoma	0.000291	0.000623	CcSEcCtD
Lisinopril—Anxiety—Epirubicin—sarcoma	0.00029	0.00062	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000289	0.000618	CcSEcCtD
Lisinopril—Discomfort—Epirubicin—sarcoma	0.000288	0.000615	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—sarcoma	0.000285	0.00061	CcSEcCtD
Lisinopril—Dry mouth—Epirubicin—sarcoma	0.000285	0.000609	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—sarcoma	0.000284	0.000608	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—sarcoma	0.000284	0.000607	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—sarcoma	0.000283	0.000606	CcSEcCtD
Lisinopril—Confusional state—Epirubicin—sarcoma	0.000281	0.000602	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—sarcoma	0.00028	0.000598	CcSEcCtD
Lisinopril—Oedema—Epirubicin—sarcoma	0.000279	0.000597	CcSEcCtD
Lisinopril—Anaphylactic shock—Epirubicin—sarcoma	0.000279	0.000597	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—sarcoma	0.000278	0.000595	CcSEcCtD
Lisinopril—Infection—Epirubicin—sarcoma	0.000277	0.000593	CcSEcCtD
Lisinopril—Cough—Doxorubicin—sarcoma	0.000276	0.00059	CcSEcCtD
Lisinopril—Shock—Epirubicin—sarcoma	0.000275	0.000587	CcSEcCtD
Lisinopril—Thrombocytopenia—Epirubicin—sarcoma	0.000273	0.000584	CcSEcCtD
Lisinopril—Tachycardia—Epirubicin—sarcoma	0.000272	0.000582	CcSEcCtD
Lisinopril—Skin disorder—Epirubicin—sarcoma	0.000271	0.00058	CcSEcCtD
Lisinopril—Hyperhidrosis—Epirubicin—sarcoma	0.00027	0.000577	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—sarcoma	0.000269	0.000576	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—sarcoma	0.000269	0.000576	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—sarcoma	0.000269	0.000576	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—sarcoma	0.000268	0.000574	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000268	0.000572	CcSEcCtD
Lisinopril—Discomfort—Doxorubicin—sarcoma	0.000266	0.000569	CcSEcCtD
Lisinopril—Anorexia—Epirubicin—sarcoma	0.000266	0.000569	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—sarcoma	0.000263	0.000563	CcSEcCtD
Lisinopril—Hypotension—Epirubicin—sarcoma	0.000261	0.000558	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—sarcoma	0.00026	0.000557	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—sarcoma	0.000258	0.000552	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—sarcoma	0.000258	0.000552	CcSEcCtD
Lisinopril—Infection—Doxorubicin—sarcoma	0.000257	0.000549	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000254	0.000544	CcSEcCtD
Lisinopril—Shock—Doxorubicin—sarcoma	0.000254	0.000543	CcSEcCtD
Lisinopril—Thrombocytopenia—Doxorubicin—sarcoma	0.000253	0.000541	CcSEcCtD
Lisinopril—Insomnia—Epirubicin—sarcoma	0.000252	0.00054	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—sarcoma	0.000252	0.000539	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—sarcoma	0.000251	0.000536	CcSEcCtD
Lisinopril—Paraesthesia—Epirubicin—sarcoma	0.000251	0.000536	CcSEcCtD
Lisinopril—Hyperhidrosis—Doxorubicin—sarcoma	0.00025	0.000534	CcSEcCtD
Lisinopril—Dyspnoea—Epirubicin—sarcoma	0.000249	0.000532	CcSEcCtD
Lisinopril—Somnolence—Epirubicin—sarcoma	0.000248	0.000531	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—sarcoma	0.000246	0.000526	CcSEcCtD
Lisinopril—Dyspepsia—Epirubicin—sarcoma	0.000246	0.000525	CcSEcCtD
Lisinopril—Decreased appetite—Epirubicin—sarcoma	0.000243	0.000519	CcSEcCtD
Lisinopril—Hypotension—Doxorubicin—sarcoma	0.000241	0.000516	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Epirubicin—sarcoma	0.000241	0.000515	CcSEcCtD
Lisinopril—Fatigue—Epirubicin—sarcoma	0.000241	0.000515	CcSEcCtD
Lisinopril—Pain—Epirubicin—sarcoma	0.000239	0.00051	CcSEcCtD
Lisinopril—Constipation—Epirubicin—sarcoma	0.000239	0.00051	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000235	0.000503	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—sarcoma	0.000234	0.000499	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—sarcoma	0.000232	0.000496	CcSEcCtD
Lisinopril—Dyspnoea—Doxorubicin—sarcoma	0.00023	0.000492	CcSEcCtD
Lisinopril—Feeling abnormal—Epirubicin—sarcoma	0.00023	0.000492	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—sarcoma	0.00023	0.000491	CcSEcCtD
Lisinopril—Gastrointestinal pain—Epirubicin—sarcoma	0.000228	0.000488	CcSEcCtD
Lisinopril—Dyspepsia—Doxorubicin—sarcoma	0.000227	0.000486	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—sarcoma	0.000225	0.00048	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000223	0.000477	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—sarcoma	0.000223	0.000476	CcSEcCtD
Lisinopril—Urticaria—Epirubicin—sarcoma	0.000222	0.000474	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—sarcoma	0.000221	0.000472	CcSEcCtD
Lisinopril—Pain—Doxorubicin—sarcoma	0.000221	0.000472	CcSEcCtD
Lisinopril—Body temperature increased—Epirubicin—sarcoma	0.000221	0.000472	CcSEcCtD
Lisinopril—Abdominal pain—Epirubicin—sarcoma	0.000221	0.000472	CcSEcCtD
Lisinopril—Feeling abnormal—Doxorubicin—sarcoma	0.000213	0.000455	CcSEcCtD
Lisinopril—Gastrointestinal pain—Doxorubicin—sarcoma	0.000211	0.000452	CcSEcCtD
Lisinopril—Hypersensitivity—Epirubicin—sarcoma	0.000206	0.00044	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—sarcoma	0.000205	0.000439	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—sarcoma	0.000204	0.000437	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—sarcoma	0.000204	0.000437	CcSEcCtD
Lisinopril—Asthenia—Epirubicin—sarcoma	0.0002	0.000428	CcSEcCtD
Lisinopril—Pruritus—Epirubicin—sarcoma	0.000197	0.000422	CcSEcCtD
Lisinopril—Diarrhoea—Epirubicin—sarcoma	0.000191	0.000408	CcSEcCtD
Lisinopril—Hypersensitivity—Doxorubicin—sarcoma	0.00019	0.000407	CcSEcCtD
Lisinopril—Asthenia—Doxorubicin—sarcoma	0.000185	0.000396	CcSEcCtD
Lisinopril—Dizziness—Epirubicin—sarcoma	0.000185	0.000395	CcSEcCtD
Lisinopril—Pruritus—Doxorubicin—sarcoma	0.000183	0.000391	CcSEcCtD
Lisinopril—Vomiting—Epirubicin—sarcoma	0.000177	0.000379	CcSEcCtD
Lisinopril—Diarrhoea—Doxorubicin—sarcoma	0.000177	0.000378	CcSEcCtD
Lisinopril—Rash—Epirubicin—sarcoma	0.000176	0.000376	CcSEcCtD
Lisinopril—Dermatitis—Epirubicin—sarcoma	0.000176	0.000376	CcSEcCtD
Lisinopril—Headache—Epirubicin—sarcoma	0.000175	0.000374	CcSEcCtD
Lisinopril—Dizziness—Doxorubicin—sarcoma	0.000171	0.000365	CcSEcCtD
Lisinopril—Nausea—Epirubicin—sarcoma	0.000166	0.000354	CcSEcCtD
Lisinopril—Vomiting—Doxorubicin—sarcoma	0.000164	0.000351	CcSEcCtD
Lisinopril—Rash—Doxorubicin—sarcoma	0.000163	0.000348	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—sarcoma	0.000163	0.000348	CcSEcCtD
Lisinopril—Headache—Doxorubicin—sarcoma	0.000162	0.000346	CcSEcCtD
Lisinopril—Nausea—Doxorubicin—sarcoma	0.000153	0.000328	CcSEcCtD
